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Abstract 
Background: The soil bacterium Pseudomonas putida is a promising platform for the production of industrially valu‑
able natural compounds. In the case of isoprenoids, the availability of biosynthetic precursors is a major limiting factor. 
In P. putida and most other bacteria, these precursors are produced from pyruvate and glyceraldehyde 3‑phosphate 
by the methylerythritol 4‑phosphate (MEP) pathway, whereas other bacteria synthesize the same precursors from 
acetyl‑CoA using the unrelated mevalonate (MVA) pathway.
Results: Here we explored different strategies to increase the supply of isoprenoid precursors in P. putida cells using 
lycopene as a read‑out. Because we were not aiming at producing high isoprenoid titers but were primarily interested 
in finding ways to enhance the metabolic flux to isoprenoids, we engineered the well‑characterized P. putida strain 
KT2440 to produce low but detectable levels of lycopene under conditions in which MEP pathway steps were not 
saturated. Then, we compared lycopene production in cells expressing the Myxococcus xanthus MVA pathway genes 
or endogenous MEP pathway genes (dxs, dxr, idi) under the control of IPTG‑induced and stress‑regulated promoters. 
We also tested a shunt pathway producing isoprenoid precursors from ribulose 5‑phosphate using a mutant version 
of the Escherichia coli ribB gene.
Conclusions: The most successful combination led to a 50‑fold increase in lycopene levels, indicating that P. putida 
can be successfully engineered to substantially increase the supply of metabolic substrates for the production of 
industrially valuable isoprenoids.
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Background
Isoprenoids (also known as terpenoids) constitute the 
largest class of natural products, with tens of thousands 
of different structures found in all kingdoms of life [1]. 
Many of them are high value compounds due to their 
diverse range of applications in areas such as human 
nutrition and pharmaceutical industry [2]. Most eco-
nomically-relevant isoprenoids are typically found at low 
levels in their natural sources. This, together with the 
increasing demand for novel isoprenoid structures with 
new or improved bioactivities, has spurred many meta-
bolic engineering and synthetic biology projects focused 
on boosting isoprenoid production. Much effort has 
been devoted towards their synthesis in microbial hosts, 
mostly employing Escherichia coli and Saccharomyces 
cerevisiae. However, interference with the endogenous 
cell metabolism and toxic effects associated with the pro-
duction of most isoprenoids, among others, are impor-
tant issues that often prevent reaching commercially 
relevant yields [3].
In this context, the stress-resistant bacterium Pseu-
domonas putida is a promising alternative platform 
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for isoprenoid production and storage. Some P. putida 
strains can tolerate much higher level of isoprenoids than 
other microorganisms (e.g. its growth is not affected by 
concentrations of the monoterpene geranic acid that 
are toxic to E. coli or S. cerevisiae [4]). The high toler-
ance to otherwise toxic compounds of P. putida cells is 
in part due to fine-tuning of lipid fluidity to adjust mem-
brane functions, activation of a general stress-response 
system, increased energy generation and induction of 
efflux pumps [5]. Additionally, P. putida is amenable to 
targeted genetic modifications and it has been targeted in 
biofactories design and biodegradation studies due to its 
robust metabolism, among others characteristics. Several 
industrial processes based on this bacterium are being 
exploited for the production of fine chemicals (e.g. 2-qui-
noxalinecarboxylic acid, 5-methylpirazine-2-carboxylic 
acid, chiral amines and 4-(hydroxypyridin-3-yl)-4-oxobu-
tyrate), and the production of many different compounds, 
including isoprenoids, is under study [6]. P. putida has 
actually been used for the production of some isopre-
noids using biotransformation approaches to obtain oxi-
dation products of the plant monoterpene limonene [7] 
or de novo biosynthesis of the monoterpene geranic acid 
[4] or the carotenoids zeaxanthin and β-carotene [8–10]. 
Despite the low number of available studies, the achieve-
ment of substantial yields of isoprenoids such as geranic 
acid and zeaxanthin and the high tolerance of P. putida to 
some of these compounds, usually toxic for other micro-
bial models, illustrate the high potential of this bacterium 
to become a platform of choice for the industrial produc-
tion of valuable isoprenoids. An important conclusion of 
these studies is that enhancing the supply of isoprenoid 
precursors is crucial for success as the bacterium only 
produces minor amounts of such precursors [7].
All isoprenoids derive from two universal 5-car-
bon (C5) precursors: isopentenyl diphosphate (IPP) 
and its double-bond isomer dimethylallyl diphosphate 
(DMAPP). In nature there are two main pathways for 
IPP and DMAPP production: the mevalonate (MVA) 
pathway and the methylerythritol 4-phosphate (MEP) 
pathway (Fig.  1). As most bacteria, P. putida only 
harbors the MEP pathway. By contrast, other bacte-
ria as well as archaea, fungi, and animal cells produce 
their isoprenoids from MVA-derived precursors [11]. 
Because IPP and DMAPP availability is limiting for 
isoprenoid biosynthesis, the MVA and MEP pathways 
have been the targets of many metabolic engineering 
efforts to increase the supply of isoprenoid precur-
sors in host cells [3]. A virtually unexplored alterna-
tive, however, is the use of non-canonical pathways to 
synthesize such precursors. Bacteria show a remark-
able plasticity for the production of their isoprenoid 
precursors. For example, the production of deoxyxy-
lulose 5-phosphate (DXP) in the first and main rate-
determining step of the MEP pathway can be achieved 
by different pathways [12]. The canonical enzyme, DXP 
synthase (DXS), produces C5 DXP from C3 pyruvate 
and glyceraldehyde 3-phosphate (GAP), but several 
mutant versions of the E. coli ribB gene were found to 
encode enzymes with a “new DXS” (or nDXS) activity 
that made DXP using alternative substrates (Fig. 1) [13, 
14]. The wild-type ribB gene encodes 3,4-dihydroxy-
2-butanone-4-phospate (DHBP) synthase, which con-
verts C5 ribulose-5-phosphate (Ru5P) into formate and 
DHBP, the biosynthetic precursor of the xylene ring of 
riboflavin [15]. Ru5P appears to be the substrate that 
nDXS enzymes convert into DXP [13].
Here we have compared the performance of previ-
ously known and novel strategies to improve the sup-
ply of IPP and DMAPP for isoprenoid biosynthesis in 
KT2440, the best characterized P. putida strain. Using 
as read-out the production of lycopene, a red carot-
enoid pigment with great commercial and nutritional 
importance, we increased isoprenoid precursor levels 
by introducing an exogenous MVA pathway for IPP and 
DMAPP synthesis, by producing DXP via nDXS, and 
by expressing DXS and other MEP pathway enzymes 
under the control of different promoters.
Fig. 1 Pathways for isoprenoid synthesis. The P. putida endogenous 
MEP pathway is shown in black. Exogenous pathways added to P. 
putida in this work are shown in color: shunt pathway from E. coli in 
green, MVA pathway from M. xanthus in blue, and lycopene pathway 
from P. ananatis in red. Enzymes are marked in bold
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Results
Pseudomonas putida KT2440 can be engineered 
for lycopene production
To use lycopene as a read-out of isoprenoid precursor 
availability in P. putida, a lycopene-producing operon 
(LYC) containing the crtE, crtB and crtI genes from Pan-
toea ananatis [16], was expressed in the strain KT2440. 
crtE encodes the enzyme geranylgeranyl diphosphate 
(GGPP) synthase, which catalyzes the addition of three 
molecules of IPP to one DMAPP unit to yield GGPP, 
the immediate precursor for carotenoids. C20 GGPP 
is converted to C40 lycopene via phytoene by phytoene 
synthase and phytoene desaturase, encoded by crtB 
and crtI respectively (Fig.  1). Two strategies were used 
to introduce the LYC operon into P. putida. First, the 
operon containing the three genes and their own pro-
moter was cloned into the vector pSEVA421 [17]. The 
plasmid obtained, p421-LYC, was introduced into the 
strain KT2440 and its ability to produce lycopene was 
compared to that of cells carrying the empty vector. 
After 24 h growing in LB, cells were harvested for lyco-
pene extraction and quantification by HPLC. While no 
lycopene was detected in empty vector control cells, 
measurable levels of this red carotenoid (1.223  ng/ml 
of culture) were found in the strain expressing the LYC 
operon (Table 1). Cell growth estimated as optical density 
at 600 nm  (OD600) was not affected in any of the strains 
(Fig. 2).
Once we confirmed the ability for lycopene synthe-
sis of P. putida cells, the crtE–crtB–crtI operon with its 
own promoter was inserted into the Tn7 att site in the 
chromosome of KT2440, using a Tn7-based delivery 
system [18], to yield the strain KTLYC. Strains KT2440 
and KTLYC were grown for 24  h in LB and lycopene 
accumulation was then measured by HPLC. Growth 
of both strains was basically identical (Fig.  2a) whereas, 
as expected, lycopene was only detected in KTLYC 
(Table 1). However, the amounts produced in this strain 
(0.106 ± 0.026 ng/ml culture) were an order of magnitude 
lower than those found in KT2440 cells containing the 
plasmid p421-LYC (Table 1), perhaps due to differences 
in copy number or DNA context (genomic vs. plasmid-
ial). In any case, these results allowed to conclude that, 
under our experimental conditions, the intermediate 
steps of the endogenous MEP pathway are not saturated 
in strain KTLYC. We therefore selected this strain for 
exploring ways of increasing the supply of MEP-derived 
isoprenoid precursors (IPP and DMAPP) in P. putida 
cells.
Lycopene production in P. putida KTLYC is enhanced 
by expressing an exogenous MVA pathway
As a first strategy to enhance the supply of metabolic 
precursors for isoprenoid biosynthesis in P. putida, we 
introduced an exogenous MVA pathway (Fig.  1) in the 
KTLYC strain. The vector pMiS1-ges-MVA, contain-
ing the bacterium Myxococcus xanthus genes required 
to convert acetyl-CoA into IPP and DMAPP under the 
control of the rhaPBAD promoter [4], was introduced 
into P. putida KTLYC. As control, the plasmid pMiS1-
ges (similar to pMiS1-ges-MVA but without the MVA 
pathway genes) was also introduced into KTLYC. Cells 
were cultured in LB medium and at the mid-exponential 
phase, expression of plasmid vector genes was induced by 
L-rhamnose. After 24 h, cells were harvested for lycopene 
extraction and quantification. Lycopene levels were esti-
mated by measuring absorbance at 472 nm, normalized 
to cell density  (OD600), and represented relative to con-
trols (Fig.  3). Lycopene production was about sevenfold 
higher in the strain harboring the MVA pathway without 
this having an impact in cell growth (Fig. 3). These results 
show that promoting the supply of IPP and DMAPP from 
Table 1 Cell density (turbidity at  600  nm) and  lycopene 
accumulation (measured by  HPLC) in  cells cultured 
during 24 h in LB
Values shown are the mean ± SD for three independent assays
Strain Cell density  (OD600nm) Lycopene 
accumulation (ng/ml 
culture)
KT2440 5.417 ± 0.791 0.000 ± 0.000
KT2440(p421) 5.293 ± 0.623 0.000 ± 0.000
KT2440(p421‑LYC) 4.930 ± 1.191 1.223 ± 0.185
KTLYC 6.157 ± 0.551 0.106 ± 0.026
Fig. 2 Cell density of P. putida strains producing lycopene. The 
indicated strains were grown in LB and their growth was measured as 
optical density at 600 nm  (OD600). Values shown are the mean ± SD of 
three independent assays
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acetyl-CoA by using an exogenous MVA pathway can 
efficiently improve lycopene production.
Up‑regulation of endogenous DXS greatly improves 
isoprenoid precursor supply in KTLYC cells
Up-regulation of the levels of several MEP pathway 
enzymes has been reported to improve flux through the 
pathway in bacteria, with the clearest effect typically 
observed with DXS when overexpressed at moderate lev-
els. To test whether DXS was also a rate-limiting enzyme 
in P. putida, the dxs gene was amplified from KT2440 
cells and cloned into the pSEVA424 plasmid [17] under 
the transcriptional control of the strong and IPTG-induc-
ible Ptrc promoter. After transformation, KTLYC cells 
harboring either the generated vector (p424-DXS) or an 
empty plasmid were cultured in LB and 1 h after inocula-
tion the medium was supplemented with different con-
centrations of IPTG. While 0.1 mM IPTG had no impact 
on culture growth, higher concentrations of the inducer 
(e.g. 0.5  mM and 1  mM) caused a much slower growth 
(Fig.  4a). Lycopene accumulation in KTLYC(p424) and 
KTLYC(p424-DXS) cells was quantified after 24  h by 
measuring absorbance at 472 nm (Fig. 4b). The presence 
of the plasmid p424-DXS caused a dramatic (15-fold) 
increase in lycopene accumulation even in the absence 
of IPTG (Fig. 4b). The positive effect of DXS on lycopene 
production was even stronger when dxs gene expression 
was induced with IPTG (25-fold). The observation that 
KT2440 cells lacking the capacity to produce lycopene 
showed very similar growth curves when transformed 
with p424-DXS and incubated with IPTG (Fig.  5) sug-
gested that the growth  phenotype is not caused by the 
accumulation of toxic levels of lycopene but results from 
the overexpression of the dxs gene. 
GGPP required for lycopene production is formed by 
adding three IPP molecules to one DMAPP acceptor, 
whereas bacterial isoprenoids are most often derived 
from farnesyl diphosphate (FPP), that is formed from 
two IPP and one DMAPP [11]. Because an unbalanced 
production of isoprenoid precursors has been shown to 
be detrimental for bacterial growth [19], we next inves-
tigated whether enhancing the interconversion of IPP 
and DMAPP might positively impact cell growth and 
lycopene accumulation in strains overexpressing DXS. 
The IPP/DMAPP ratio is regulated by the enzyme iso-
pentenyl diphosphate isomerase (IDI) that interconverts 
IPP and DMAPP molecules (Fig.  1). The idi gene from 
E. coli was cloned into the p424-DXS vector and the 
resulting p424-IDI-DXS plasmid was introduced into the 
strain KTLYC. Positive transformants were grown with 
or without IPTG as described above (Fig.  4c) and both 
cell growth and lycopene accumulation were recorded 
at 24 h (Fig. 4d). In the absence of IPTG, lycopene pro-
duction tended to be slightly higher in cells harboring 
p424-IDI-DXS compared to p424-DXS, but the differ-
ence was not statistically significant. Induction with 
increasing concentrations of IPTG did not improve cell 
growth or lycopene production on cells harboring p424-
IDI-DXS (Fig.  4d) compared to p424-DXS (Fig.  4b). On 
the contrary, growth of KTLYC(p424-IDI-DXS) cells 
was reduced compared to that of IDI-lacking strains at 
IPTG concentrations higher than 0.1  mM. Addition of 
1 mM IPTG to the medium also reduced the capacity of 
the cells for lycopene accumulation (Fig. 4). In summary, 
IPP/DMAPP imbalance might influence lycopene bio-
synthesis but it appears not to be a major factor limiting 
lycopene yields in P. putida cells. While DXS activity is 
much more relevant to regulate flux to isoprenoid bio-
synthesis, a fine control of its levels is critical to prevent 
deleterious effect on cell growth.
Use of the stress‑regulated promoter PkatA to express IDI 
and DXS has a modest effect on lycopene production
To overcome the toxic effects associated with a too strong 
DXS activity, we next looked for alternative promoters 
that could be down-regulated when cell growth is com-
promised. As starting point, we studied the expression of 
Fig. 3 Lycopene production in P. putida KTLYC cells harboring the 
MVA pathway. KTLYC cells transformed with vectors either containing 
or not the MVA pathway were cultured in LB. Expression of the MVA 
pathway operon was induced 3 h after inoculation by adding 0.2% 
(w/v) L‑rhamnose to the culture. After 24 h, cell growth was estimated 
as optical density at 600 nm  (OD600) and lycopene accumulation 
was calculated by measuring the absorbance at 472 nm of acetone 
extracts. a  OD600 values. b Lycopene levels normalized to cell 
density and represented relative to those in cells without the MVA 
pathway. Values shown are the mean ± SD of three independent 
assays. The asterisk indicates statistically significant difference (T test, 
P‑value < 0.05)
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the stress-regulated genes ccoN (PP4250), cioA (PP4651) 
and katA (PP0481) in KTLYC(p424-IDI-DXS) and 
KTLYC(p424) cells exposed to different concentrations 
of IPTG (Fig. 6a). The operons ccoN1O1Q1P1 and cioAB 
encode two terminal oxidases, the cytochrome cbb3-1 
oxidase and the cyanide-insensitive oxidase (CIO), 
Fig. 4 Cell density and lycopene content of P. putida KTLYC cells overproducing DXS. Overnight cultures of KTLYC cells transformed with the 
indicated vectors were inoculated in LB. Expression of the cloned genes was induced 1 h after inoculation by adding the indicated amounts of 
IPTG (mM) to the culture. After 24 h, growth was estimated from optical density at 600 nm  (OD600) and lycopene accumulation was calculated 
by measuring the absorbance at 472 nm of acetone extracts. a Cell density kinetics of KTLYC cells transformed with either p424‑DXS or empty 
pSEVA424 plasmids, estimated from  OD600 values. b Cell density and lycopene content of the strains shown in a at 24 h. c Cell density kinetics of 
KTLYC cells transformed with either p424‑IDI‑DXS or empty pSEVA424 plasmids, estimated from  OD600 values. d Cell density and lycopene content 
of the strains shown in c at 24 h. Values shown are the mean ± SD of three independent assays. Asterisks indicate statistically significant differences 
(T‑test, P‑value < 0.05 * or 0.01 **) relative to KTLYC(p424) controls grown without IPTG
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respectively, and they are up-regulated under low-oxygen 
conditions [20]. The expression of the katA gene, encod-
ing one of the major peroxide-degrading enzyme directly 
eliminating oxidants in the cell, is regulated by matric and 
oxidative stress [21]. The levels of ccoN, cioA and katA 
transcripts in the two strains under different growth con-
ditions were estimated by real time quantitative RT-PCR 
and represented as relative fold-changes in KTLYC(p424-
IDI-DXS) compared to KTLYC(p424) cells (Fig.  6a), No 
changes were observed in the case of ccoN whereas cioA 
mRNA levels were drastically reduced in KTLYC(p424-
IDI-DXS) cells independent of IPTG concentration 
(i.e. regardless of DXS levels). In the case of katA, simi-
lar transcript levels were found in the two strains when 
growing without the inductor but were reduced in 
KTLYC(p424-IDI-DXS) when IPTG was added to the 
medium to induce idi-dxs co-transcription (Fig. 6a). The 
reduction was moderate with 0.1 mM IPTG, a concentra-
tion that hardly impacts growth of this strain (Fig.  4c). 
When growth was inhibited at 0.5  mM IPTG, however, 
a clear sixfold reduction in katA expression was detected 
(Fig.  6a). We therefore concluded that the PkatA pro-
moter might be repressed when DXS (and IDI) activities 
are high enough to cause growth-repressing effects.
With the aim of adjusting enhanced isoprenoid pre-
cursor supply to actual cell metabolism and growth, we 
next used the PkatA promoter [22] to construct a syn-
thetic PkatA-idi-dxs operon. KTLYC strains harbor-
ing the plasmids pPkatA-IDI-DXS or p424-IDI-DXS, as 
well as the empty pSEVA424 vector, were cultured in LB 
without IPTG and lycopene accumulation levels were 
analyzed every 24  h during 5  days. After the first 24  h 
(Fig.  6b) KTLYC(pPkatA-IDI-DXS) cells showed four-
fold higher levels of lycopene than KTLYC(p424) but half 
as much compared to KTLYC(p424-IDI-DXS). Neither 
KTLYC(pPkatA-IDI-DXS) nor KTLYC(p424-IDI-DXS) 
cells produced more lycopene at longer incubation times 
(Fig.  6c). It is therefore possible that the Ptrc promoter 
present in the p424-IDI-DXS construct leads to higher 
enzyme levels than the PkatA promoter even without the 
IPTG inducer, hence being more efficient to increase the 
MEP pathway flux.
Depletion of pyruvate and GAP might contribute to the cell 
growth defects associated with DXS overexpression
When KT2440 cells are grown in the presence of glu-
cose, they run a biochemical cycle that merges activi-
ties belonging to the Entner–Doudoroff (ED) pathway, 
the Embden–Meyerhof–Parnas (EMP) pathway and 
the pentose phosphate pathway that produces equimo-
lar amounts of pyruvate and GAP, favors NADPH for-
mation, and helps the bacteria to cope from different 
types of environmental stress [6, 23]. To test whether 
the defective growth phenotype observed in DXS-over-
producing P. putida cells might result from metabolic 
imbalance caused by low pyruvate and GAP levels, we 
grew KTLYC(p424-DXS) and KTLYC(p424) cells in LB 
either supplemented or not with 50  mM glucose. IPTG 
was added at high concentration (1  mM) at the begin-
ning of the exponential phase and cell growth and lyco-
pene accumulation were analyzed after 24  h. As shown 
in Fig.  7, the sharp difference in cell growth between 
KTLYC(p424-DXS) and KTLYC(p424) strains was com-
pletely abolished in glucose-supplemented medium. 
Glucose, but not other carbon sources such as citrate or 
succinate, also rescued growth defects observed when 
cells were grown in minimal M9 medium (Fig. 7). These 
results support the conclusion that depletion of GAP and 
pyruvate when DXS levels are too high is a major cause 
for the growth defects observed in engineered P. putida 
cells. Furthermore, the addition of glucose to LB medium 
increased lycopene accumulation per cell (Fig.  7), sug-
gesting that IPP and DMAPP supply for isoprenoid 
biosynthesis could be improved by increasing the avail-
ability of both GAP and pyruvate or by finding alternative 
sources for DXP synthesis.
It was previously reported that single mutations in the 
E. coli ribB gene, encoding DHBP synthase, allow the 
mutant enzymes (nDXS) to produce DXP from Ru5P 
and hence complement the absence of the DXS enzyme 
in E. coli [13, 14]. Because DXP production by nDXS 
enzymes does not directly consume pyruvate and GAP 
Fig. 5 Effect of DXS overproduction on KT2440 cell growth. P. 
putida KT2440 cells harbouring the vector p424‑DXS or the empty 
pSEVA424 plasmid were inoculated in LB and, after 1 h, the medium 
was supplemented with the indicated concentration of IPTG (mM). 
Increase in cell growth was measured as optical density at 600 nm 
 (OD600). Values shown are the mean ± SD of three independent assays
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and it is less efficient compared to DXS, we reasoned 
that using nDXS enzymes might overcome some of the 
problems associated with DXS overexpression. Although 
several mutations in ribB allow DXP synthesis, for this 
work we used the nDXS version harboring a missense 
mutation resulting in a G108S change [13, 14]. Follow-
ing a similar strategy to that described for DXS, we gen-
erated the plasmid p424-nDXS and used it to transform 
KTLYC cells. The resulting strain and the KTLYC(p424) 
control were cultured in LB in the absence or presence 
of IPTG (added 1 h after inoculation) and lycopene accu-
mulation was analyzed after 24  h. Unlike that observed 
for KTLYC(p424-DXS) and KTLYC(p424-IDI-DXS) 
strains (Fig.  4), growth of KTLYC(p424-nDXS) cells 
was not affected by IPTG at any of the concentrations 
tested (Fig. 8a). Also different to DXS-producing strains, 
KTLYC cells producing nDXS showed a good correla-
tion between IPTG and lycopene levels (Fig.  8b). How-
ever, lycopene accumulation in KTLYC(p424-nDXS) cells 
at the highest IPTG concentration tested (1  mM) was 
only threefold higher than that reached in the absence of 
inducer (Fig. 8b).
Ru5P, the substrate of nDXS, is an intermediate of the 
pentose phosphate pathway, which is not very active in 
P. putida [6, 23]. In complete (LB) medium, the addition 
of 50  mM glucose had no effect on lycopene produc-
tion when KTLYC(p424-nDXS) cells were induced with 
1  mM IPTG (Fig.  7). In minimal (M9) medium, similar 
levels of lycopene were produced with glucose, citrate, or 
succinate. It is interesting, however, that whereas lyco-
pene accumulation in KTLYC(p424-DXS) cells was much 
lower in M9 than in LB medium, KTLYC(p424-nDXS) 
Fig. 6 Test of the P. putida PkatA promoter. a Transcript levels of ccoN, cioA and katA in KTLYC(p424‑IDI‑DXS) cells grown in the presence of the 
indicated concentrations of IPTG. The graph represents the ratio of the mRNA levels in KTLYC(p424‑IDI‑DXS) cells relative to KTLYC(p424) controls 
grown under the same conditions. Error bars indicate SD. b Lycopene accumulation in the indicated strains grown for 24 h in LB without IPTG. 
Values shown are the mean ± SD of three independent assays. Asterisks indicate statistically significant differences (T‑test, P‑value < 0.05 * or 0.01 
**) relative to KTLYC(p424) controls. c Lycopene accumulation in the indicated strains grown in LB without IPTG for the indicated times (in hours). 
Values are shown relative to 24 h samples and represent the mean ± SD of three replicates in two independent assays
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cells showed similar lycopene levels in both media 
(Fig. 7). We therefore conclude that the main factor lim-
iting isoprenoid production in the KTLYC(p424-nDXS) 
strain is not Ru5P availability but the capacity of nDXS to 
synthesize DXP.
Combination of DXS and DXR further increases lycopene 
accumulation
As a last strategy to up-regulate the endogenous MEP 
pathway and increase lycopene synthesis in P. putida 
KTLYC, the endogenous enzyme DXP reductoisomerase 
(DXR) was overproduced in this strain either alone or 
together with DXS. DXR catalyzes the second step of the 
MEP pathway, i.e. the reduction of DXP to MEP (Fig. 1). 
After generating construct p424-DXS-DXR and trans-
forming KTLYC cells, growth of the generated strain in 
LB medium was monitored upon adding IPTG 1 h after 
inoculation (Fig.  9). In agreement with our conclusion 
that cell growth defects observed when the MEP path-
way flux is up-regulated are mainly due to depletion of 
pyruvate and GAP, growth of KTLYC(p424-DXS-DXR) 
cells was compromised even at low concentrations of 
IPTG such as 0.1 mM (Fig. 9), which had no impact on 
the growth of KTLYC(p424-DXS) cells (Fig.  4a). To test 
whether the expected up-regulation of the MEP path-
way flux in KTLYC(p424-DXS-DXR) cells had a positive 
impact on lycopene accumulation, we next compared 
the levels of this carotenoid in KTLYC cells transformed 
with p424-DXS-DXR, p424-DXS, or with an empty vec-
tor and treated with 0.1 mM IPTG 1 h after inoculation. 
After 24  h, cells harboring the p424-DXS-DXR con-
struct accumulated 50-fold higher lycopene levels per 
cell that KTLYC(p424) control. When compared to cells 
overexpressing only one of the two MEP pathway genes, 
KTLYC(p424-DXS-DXR) cells produced twice as much 
lycopene as KTLYC(p424-DXS) (Fig. 10).
Discussion
Improving the supply of IPP and DMAPP for the bio-
technological production of value-added isoprenoids 
in microorganisms has been the target of many stud-
ies. However, many other factors need to be taken into 
account to achieve an efficient production of isoprenoids 
without affecting the fitness of the cell. They include (A) 
depletion of metabolic substrates, (B) toxicity of accumu-
lated intermediates or end products, and (C) saturation 
of the cell storage capacity. Strategies to deal with the last 
two problems are abundant, but less attention has been 
paid to the first, despite the negative growth impact of 
diverting the pools of central metabolites such as pyru-
vate and GAP to the synthesis of IPP and DMAPP. While 
most studies aimed to improve IPP and DMAPP supply 
have been done with well-characterized organisms such 
as E. coli (a model for bacteria that use the MEP pathway) 
and S. cerevisiae (a model for yeasts, which only use the 
MVA pathway), other microorganisms that show addi-
tional advantages for the production and accumulation 
of high isoprenoid titers remain scarcely explored. This 
is the case with P. putida, a bacterium that shows a very 
high tolerance to toxic compounds such as monoterpenes 
[4, 5]. An additional advantage of P. putida is that glucose 
is metabolized to produce balanced amounts of the MEP 
pathway substrates pyruvate and GAP [6, 10, 23]. These 
central metabolic substrates are produced in non-equiv-
alent amounts in other bacteria such as E. coli, where this 
Fig. 7 Growth and lycopene levels of KTLYC cells producing 
either DXS or nDXS. The strains KTLYC(p424), KTLYC(p424‑DXS) and 
KLYC(p424‑nDXS) were cultured in the indicated mediums: LB, LB 
supplemented with 50 mM glucose, or M9 minimal salt medium 
containing 50 mM glucose, 30 mM citrate or 30 mM succinate as 
carbon source. Expression of genes encoding DXS or nDXS was 
induced with 1 mM IPTG 1 h after inoculation. After 24 h, growth 
was estimated as optical density at 600 nm  (OD600) (upper graph) 
and lycopene accumulation was calculated by measuring the 
absorbance at 472 nm of acetone extracts of the cells and normalized 
to cell density (lower graph). Values shown are the mean ± SD of 
three independent assays. Asterisks indicate statistically significant 
differences (T‑test, P‑value < 0.05 * or 0.01 **) relative to KTLYC(p424) 
controls
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Fig. 8 Growth and lycopene content of P. putida KTLYC cells 
overproducing nDXS. KTLYC cells transformed with the indicated 
vectors were cultured in LB. Expression of the cloned genes was 
induced 1 h after inoculation by adding the indicated amounts of 
IPTG (mM) to the culture. After 24 h, growth was measured as optical 
density at 600 nm  (OD600) and lycopene accumulation was calculated 
by measuring the absorbance at 472 nm of acetone extracts. a Cell 
density kinetics of KTLYC cells transformed with either p424‑nDXS 
or empty pSEVA‑424 plasmids estimated from  OD600 values. b Cell 
density and lycopene content of the strains shown in a at 24 h. Values 
shown are the mean ± SD of three independent assays. Asterisks 
indicate statistically significant differences (T‑test, P‑value < 0.05) 
relative to KTLYC(p424) controls grown without IPTG
supply of pyruvate and GAP is also important to upregu-
late isoprenoid production while preventing major inter-
ferences with overall microbial metabolism leading to 
defective growth.
To investigate different ways of stimulating the meta-
bolic flux through the endogenous MEP pathway to 
isoprenoid precursors, we generated a P. putida strain 
(KTLYC) with an exogenous 3-gene operon to produce 
lycopene as a read-out. By transforming this strain with 
plasmids to either overexpress endogenous MEP path-
way genes or incorporate alternative shunt pathways, 
we could multiply lycopene production (i.e. IPP and 
DMAPP supply) by 3 (with nDXS; Fig.  8), 7 (with the 
MVA pathway; Fig. 3), 25 (with DXS; Fig. 4) and 50 (with 
DXS and DXR; Fig.  10). It is most likely, however, that 
further optimization of at least some of these strategies 
◂
imbalanced availability of pyruvate and GAP can limit the 
activity of the MEP pathway [24]. Increasing the levels of 
both pyruvate and GAP in P. putida actually led to an 
increase (1.3-fold) in carotenoid (β-carotene) production 
[10], suggesting that the supply of metabolic substrates 
limits the MEP pathway flux. Our data reported here 
further support the conclusion that ensuring a proper 
Fig. 9 Cell growth of P. putida KTLYC strains overproducing DXS 
and DXR. Overnight cultures of KTLYC cells transformed with the 
indicated plasmids were inoculated in LB and, after 1 h, the indicated 
concentration of IPTG (mM) was added to the medium. Graph shows 
the increase in cell density at 600 nm  (OD600). Values shown are the 
mean ± SD of three independent assays
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or a combination of several could result in even higher 
increases. Additive and synergistic effects could also be 
achieved by improving the supply of MEP pathway sub-
strates. A recent example is the rewiring of the P. putida 
core metabolism for glucose assimilation from the native 
Entner–Doudoroff to the linear Embden–Meyerhof–Par-
nas glycolysis, which improved the production of both 
pyruvate and GAP [10]. The metabolic plasticity shown 
by P. putida, which is able to metabolize a broad variety 
of carbon sources including fatty acids, glycerol and aro-
matic compounds [25], provides an additional opportu-
nity to redesign the pools of substrates required for the 
synthesis of IPP and DMAPP. Feeding the bacteria with 
different carbon sources might help accumulate higher 
pools of pyruvate, GAP (i.e. glucose) or acetyl-CoA (i.e. 
fatty acids) and the combination of different carbon 
sources could help release the competition of the pro-
ductive (exogenous) pathways with the housekeeping 
(endogenous) metabolism. The hierarchical utilization 
of different carbon sources [26] might limit our ability to 
combine fully active metabolic pathways to simultane-
ously feed productive and housekeeping pathways in the 
cell. However, our knowledge of the mechanisms control-
ling this hierarchy are constantly improving [27, 28], pro-
viding new engineering opportunities.
Among the novel strategies tested here, the use of 
nDXS to produce DXP from Ru5P was most successful as 
it improved lycopene accumulation up to threefold with-
out negatively affecting cell growth (Fig.  8). While this 
increase is still far from that achieved with the canonical 
DXS enzyme (Fig. 4), it is important to keep in mind that 
nDXS was identified as a mutant enzyme which acquired 
the ability to produce DXP as a result of a point mutation 
and it is not optimized for DXP synthesis. Our estima-
tion is that only about 10% of the Ru5P substrate is trans-
formed into DXP by nDXS. Increasing the DXS activity 
of the mutant enzyme should be feasible and even fast if 
using the new automatized platforms available for adap-
tive laboratory evolution approaches [29, 30]. An opti-
mized nDXS would allow a complementary strategy 
using the canonical DXS to push the MEP pathway using 
pyruvate and GAP up to the limits that show no effect 
on growth with an additional DXP input obtained from 
the transformation of Ru5P by nDXS. The availability of 
the crystal structure of the wild-type ribB protein [31] 
should allow to infer how the newly selected mutations 
could affect the DXS activity of nDXS, an information 
that could be very valuable to eventually create syn-
thetic enzymes able to produce DXP from Ru5P or from 
substrates that do not interfere with the endogenous 
MEP pathway or other essential metabolic processes 
in the bacteria. As a complementary strategy, the sup-
ply of Ru5P might be enhanced by rewiring the pentose 
Fig. 10 Cell growth and lycopene accumulation in P. putida KTLYC 
cells overproducing DXS and DXR. Overnight cultures of KTLYC 
cells transformed with the indicated vectors were inoculated in LB 
and induced to express the cloned genes with 0.1 mM IPTG added 
1 h after inoculation. a Cell density kinetics of the indicated strains 
estimated from  OD600 values. b Cell density and lycopene content 
of the strains shown in a at 24 h. Values shown are the mean ± SD of 
three independent assays. Asterisks indicate statistically significant 
differences (T‑test, P‑value < 0.05 * or 0.01 **) relative to KTLYC(p424) 
controls
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phosphate pathway. Ru5P is a C5 substrate and hence 
it is converted into DXP by nDXS without losing car-
bon (unless the reaction catalyzed by DXS, which starts 
with two C3 precursors and involves a decarboxylation). 
Together, the use of optimized versions of nDXS either 
alone or in combination with other strategies might 
increase IPP and DMAPP production to new high levels.
Another novel strategy that we tested was the fine 
regulation of DXS expression by using an endogenous 
promoter that responded to cell growth stress (Fig.  6). 
Using the PkatA promoter we only achieved a fourfold 
increase in lycopene accumulation compared to empty 
plasmid controls, suggesting that the transcriptional 
activity of this promoter in the conditions tested is too 
low to effectively boost the MEP pathway and hence to 
reach the stress conditions that could eventually repress 
transcription. It is likely that the use of stronger but 
still stress-responsive promoters might work better. 
The PkatA promoter might be engineered to increase 
its transcriptional activity while preserving its regula-
tory traits. Alternatively, analysis of the transcriptome 
of KTLYC(p424-DXS) cells grown in the presence of dif-
ferent concentrations of IPTG should allow to identify 
genes that are highly expressed when cells grow normally 
but are repressed when cell growth is compromised in an 
IPTG-dependent fashion (i.e. when DXS activity is too 
high). The promoters of such genes might be then used in 
synthetic operons to increase the supply of DXS (and IDI, 
DXR, nDXS, etc.) and hence the availability of isoprenoid 
precursors under optimal growth conditions but down-
regulate them when growth-repressing effects appear. 
This will give time to the cells to readjust their metabo-
lism and retake isoprenoid overproduction afterwards.
The more “classical” approaches that we tested, i.e. 
the use of an exogenous MVA pathway to produce IPP 
and DMAPP from acetyl-coA and the overexpression of 
MEP pathway genes, led us to conclude that we cannot 
directly extrapolate the results obtained with one bacte-
rium (e.g. E. coli) to engineer another bacterium (e.g. P. 
putida). For example, using the MVA pathway typically 
works better than DXS up-regulation in E. coli [32–34] 
but we observed the opposite behavior in P. putida. A 
similar observation was previously reported in cyanobac-
teria growing in photoautotrophic conditions to produce 
isoprene [35]. The presence of the bacterial MVA path-
way operon improved lycopene accumulation by seven-
fold (Fig.  3), similar to the tenfold increase reported to 
cause the same operon on monoterpene production in P. 
putida DSM 12264 cells [4]. By contrast, the presence of 
a plasmid containing DXS was able to promote lycopene 
accumulation in KTLYC cells by 15-fold in the absence 
of any induction (Fig.  4b). The almost complete lack of 
effect of IDI overproduction on lycopene synthesis when 
the limiting role of DXS is released in P. putida (Fig. 4d) 
is also different to that observed in E. coli [29].
Conclusion
Production of isoprenoids has been extensively engi-
neered in classical microbial chassis such as E. coli and 
S. cerevisiae but much less effort has been made in P. 
putida despite the unique characteristics that make 
this organism a very attractive host for the industrial 
production of these metabolites. The present work 
analyzed different ways of enhancing the supply of iso-
prenoid precursors (IPP and DMAPP) in P putida strain 
KT2440 using lycopene as read-out. The most success-
ful combination led to a 50-fold increase of lycopene 
accumulation. Under our experimental conditions, the 
production of limonene in P. putida cells engineered to 
synthesize this monoterpene was also boosted by the 
same MEP pathway constructs that improved lycopene 
levels, supporting the conclusion that the increases we 
observed in downstream isoprenoid products are indic-
ative of a major up-regulation of the metabolic flux to 
IPP and DMAPP. Our work therefore represents an ini-
tial but important step towards engineering P. putida 
cells to produce high isoprenoid titers. The unique met-
abolic plasticity of P. putida together with its astonish-
ing capacity to tolerate high levels of toxic isoprenoids 
such as monoterpenes and its amenability to genetic 
engineering make this bacterium a promising candidate 
to become a favorite microbial cell factory to produce 
high-value isoprenoids.
Methods
Bacterial strains and culture media
Escherichia coli and P. putida cells were cultured at 
37  °C and 30  °C, respectively, with strong aeration. LB 
broth (10 g/l tryptone; 5 g/l yeast extract, 10 g/l NaCl) 
was used as complete growth medium. M9 minimal 
salts medium [36] was supplemented with trace ele-
ments [37], and either 30 mM citrate, 30 mM succinate 
or 50 mM glucose as the carbon source. When needed, 
antibiotic were added at the following concentrations: 
kanamycin 25  μg/ml, gentamicin 25  μg/ml, strepto-
mycin 50  μg/ml (or 500  μg/ml when the host strain 
harboured a gentamicin-resistance determinant), ampi-
cillin 100 μg/m. Cell density was monitored by measur-
ing turbidity (optical density) at 600 nm  (OD600).
To generate strain KTLYC, a 3788 bp DNA fragment 
containing the P. ananatis genes crtE, crtB and crtI and 
their own promoter was PCR-amplified from the vec-
tor pACCRT-EIB [16] and cloned into the NotI site of 
the Tn7-based delivery vector pTn7-M [18]. The gener-
ated plasmid, named pTn7-M-LYC, was transferred to 
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P. putida strain KT2440 by tetra-partite mating using 
E. coli cc118λpir (pTnS1) as the supplier of Tn7 trans-
posase and E. coli HB101 (pRK600) as the transfer 
function donor, as previously described [18]. The cor-
rect insertion of the transposon at the att Tn7 site of 
the P. putida genome was checked by sequencing.
Plasmids
Plasmid p421-LYC contains the crtE, crtB and crtI genes 
and their own promoter from P. ananatis. To generate 
this vector, the same 3788 bp DNA fragment inserted in 
the genome of the strain KTLYC was cloned in the NotI 
site of the vector pSEVA421 [17]. The pMiS1-ges-mva 
vector [4] contains the MVA pathway from M. xanthus 
under the control of the promoter rhaPBAD; transcrip-
tion from this promoter can be induced by addition of 
L-rhamnose. To overproduce P. putida or E. coli enzymes 
involved in IPP and DMAPP synthesis, genes coding for 
these enzymes were cloned downstream of the IPTG-
inducible promoter Ptrc in the vector pSEVA424 [17]. To 
construct the p424-DXS vector, a DNA fragment includ-
ing the rbs region of the vector pET23 and the coding 
region of P. putida dxs gene was cloned between the sites 
EcoRI and HindIII of plasmid pSEVA424. Plasmid p424-
nDXS was made in a similar way using a version of the 
E. coli ribB gene harboring the G108S mutation [14]. 
The p424-DXS plasmid was used as a backbone to clone 
the idi gene from E. coli (upstream of dxs, in the EcoRI 
site, rendering plasmid p424-IDI-DXS) or the P. putida 
dxr gene (downstream of dxs, between HindIII and SpeI, 
rendering p424-DXS-DXR). The Ptrc promoter in the 
vector p424-IDI-DXS was replaced with the P. putida 
PkatA promoter after PCR amplification using primers 
katA-PacI-F (5′-T G T T A A T T A A G A C G T T C T 
G T C T G C T A C) and katA-AvrII-R (5′-C T C C T A 
G G G C C G G C T A A T C G G) and cloning between 
the PacI and AvrII sites to create plasmid pPkat-IDI-DXS. 
All plasmid constructs were sequenced and the plas-
mids transferred to P. putida by triparental mating using 
pRK600 as a donor of transfer functions.
Quantification of lycopene accumulation
An overnight culture of the strain of interest was diluted 
to a final turbidity  (OD600) of 0.05 in fresh LB medium. 
The indicated amount of IPTG or L-rhamnose was added 
to induce transcription from promoters Ptrc or Pram 
respectively. Cells were allowed to grow at 30  °C with 
vigorous aeration. After 24  h, cell growth was meas-
ured  (OD600) and 5  ml aliquots were taken to lycopene 
extraction with acetone and quantification by measuring 
absorbance at 472 nm, as described at Rodríguez-Villalón 
et  al. [38]. Three independent assays were performed. 
When indicated, lycopene levels were also measured by 
HPLC in an Agilent 1200 series HPLC system (Agilent 
Technologies), as previously described [39].
RNA purification
The KTLYC(p424-IDI-DXS) strain was grown in LB 
medium at 30 °C in aerated flask and after 1 h the indi-
cated IPTG concentration was added. At the start of the 
stationary phase  (OD600 = 2.2), 1 ml of samples were col-
lected, harvested by centrifugation and immediately fro-
zen at − 70  °C. RNA was purified from cell pellet using 
RNeasy RNA Purification Kit (Qiagen) following the 
manufacturer’s instructions. Purified RNA was treated 
with RNase-free DNase I (Ambion), as specified by the 
manufacturer. RNA was quantified using a NanoDrop 
(Thermo Scientific) and its integrity was analyzed by 
agarose gel electrophoresis. The absence of DNA was 
confirmed by real-time PCR using primers for rpoN, as 
previously described [40].
Real‑time RT‑PCR
Real-time RT-PCR assay was performed using total RNA 
preparations obtained from three independent cultures 
(three biological replicates). RNA was reverse-tran-
scribed into cDNA using the first-strand cDNA synthesis 
kit (Roche) according to the manufacturer’s instructions. 
Real-time PCR was performed using LightCycler 480 
SYBR Green I Master (Roche) and 0.3 μM of each primer 
on a LightCycler 480 Real-Time PCR System (Roche). 
RNA levels were analyzed by relative quantization as 
previously described [40]. The primers used are listed in 
Table 2.
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